These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 16673281

  • 1. Diagnosis and therapy of polycythemia vera.
    Lengfelder E, Merx K, Hehlmann R.
    Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
    [Abstract] [Full Text] [Related]

  • 2. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J, Penka M, Campr V, Pospísilová D, Kren L, Nováková L, Bodzásová C, Brychtová Y, Cerná O, Dulícek P, Joniásová A, Kissová J, Korístek Z, Schützová M, Vonke I, Walterová L.
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [Abstract] [Full Text] [Related]

  • 3. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 4. Polycythemia vera: scientific advances and current practice.
    Tefferi A, Spivak JL.
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [Abstract] [Full Text] [Related]

  • 5. [Diagnosis and therapy of polycythemia vera in the era of JAK2].
    Lengfelder E.
    Dtsch Med Wochenschr; 2013 Feb; 138(7):331-6. PubMed ID: 23393003
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data.
    Finazzi G.
    Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282
    [Abstract] [Full Text] [Related]

  • 7. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 8. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G, Barbui T.
    Cancer J; 2007 Nov 12; 13(6):372-6. PubMed ID: 18032974
    [Abstract] [Full Text] [Related]

  • 9. Polycythemia vera: a review.
    Golden C.
    Clin J Oncol Nurs; 2003 Nov 12; 7(5):553-6. PubMed ID: 14603552
    [Abstract] [Full Text] [Related]

  • 10. Polycythemia vera.
    Stuart BJ, Viera AJ.
    Am Fam Physician; 2004 May 01; 69(9):2139-44. PubMed ID: 15152961
    [Abstract] [Full Text] [Related]

  • 11. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
    Barbui T, Finazzi G.
    Semin Thromb Hemost; 2007 Jun 01; 33(4):321-9. PubMed ID: 17525889
    [Abstract] [Full Text] [Related]

  • 12. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.
    Leuk Res; 2007 Aug 01; 31(8):1031-8. PubMed ID: 17367853
    [Abstract] [Full Text] [Related]

  • 13. An inhibitor of Janus kinase 2 prevents polycythemia in mice.
    Mathur A, Mo JR, Kraus M, O'Hare E, Sinclair P, Young J, Zhao S, Wang Y, Kopinja J, Qu X, Reilly J, Walker D, Xu L, Aleksandrowicz D, Marshall G, Scott ML, Kohl NE, Bachman E.
    Biochem Pharmacol; 2009 Aug 15; 78(4):382-9. PubMed ID: 19413997
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr 15; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 18. Treatment of polycythemia vera.
    Silver RT.
    Semin Thromb Hemost; 2006 Jun 15; 32(4 Pt 2):437-42. PubMed ID: 16810620
    [Abstract] [Full Text] [Related]

  • 19. [Polycythemia vera].
    Rain JD.
    Rev Prat; 2005 Oct 15; 55(15):1659-68. PubMed ID: 16334202
    [Abstract] [Full Text] [Related]

  • 20. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS, Pallisgaard N, Møller MB, Hasselbalch HC.
    Eur J Haematol; 2007 Dec 15; 79(6):508-15. PubMed ID: 17961178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.